Introduction {#section5-0004867418791257}
============

Borderline personality disorder (BPD) is the most common personality disorder and affects approximately 0.7--2% of the population ([@bibr45-0004867418791257]). The disorder has a substantial negative impact on people's lives, demonstrated by poor functioning, high (attempted) suicide rate, and high mental and physical comorbid problems ([@bibr40-0004867418791257]; [@bibr44-0004867418791257]). Pharmacotherapy is usually not advised to address general BPD severity ([@bibr26-0004867418791257]; [@bibr36-0004867418791257]), yet psychological treatments have been examined and some have shown benefit ([@bibr11-0004867418791257]; [@bibr36-0004867418791257]; [@bibr42-0004867418791257]). Among these psychological treatments, four were designed to specifically address BPD, and these may be superior to others ([@bibr5-0004867418791257]; [@bibr11-0004867418791257]; [@bibr23-0004867418791257]; [@bibr42-0004867418791257]). We have called these 'specialized psychotherapies' and they are dialectical behavior therapy (DBT), mentalization-based treatment (MBT), transference-focused therapy (TFP) and schema therapy (ST; formerly schema-focused therapy, SFT). Specialized psychotherapies share several commonalities: they are all are based on theories about the etiology and maintaining factors of BPD and have published detailed protocols on the treatment of BPD and therapeutic techniques, as well as on managing the therapeutic relationship. In other words, only specialized psychotherapies specifically designed as a 'complete therapy' for BPD were included, but generic treatments as cognitive behavioral therapy (CBT), and adjunct treatments as systems training for emotional predictability and problem solving (STEPPS) are not.

A comprehensive meta-analysis on non-pharmacological interventions by [@bibr42-0004867418791257] investigated the effectiveness of individual specialized psychotherapies for BPD and found low certainty of the evidence due to the small number of studies for each specialized psychotherapy separately. Since then, the number of randomized controlled trials (RCTs) and follow-up of existing studies has increased. A recent meta-analysis by [@bibr11-0004867418791257] included all specialized and other psychotherapies. Cristea et al. pooled psychotherapies together on a high aggregated level (standalone vs add-on) and grouped the outcomes in categories to create a strong evidence base. However, their review does not focus on the effectiveness of specialized psychotherapies and did not include studies in which one psychotherapy was compared to another psychotherapy (head-to-head trials) to examine the comparative effectiveness.

Aims {#section6-0004867418791257}
----

The aim of our meta-analysis was to investigate whether specialized psychotherapies are effective for adults with BPD on overall BPD severity, single BPD symptoms (e.g. avoidance of abandonment, dysfunctional interpersonal patterns, identity disturbance, impulsivity, suicidal ideation, suicidal behavior, self-injurious behavior, affective instability, feelings of emptiness, anger and dissociative symptoms) and dropout. By pooling all specialized psychotherapies together we aim to create a more solid and clinically useful evidence base. In addition, we investigated the comparative effectiveness of individual specialized psychotherapies.

Methods {#section7-0004867418791257}
=======

The review is reported following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines ([@bibr34-0004867418791257]).

Eligibility criteria {#section8-0004867418791257}
--------------------

We included RCTs on four specialized psychotherapies (DBT, MBT, TFP and ST) for adults (18 years and older) with BPD, which included an individual psychotherapy component and had a duration of 16 weeks or more. Eligible comparison groups were other protocolized and specialized psychotherapies, or control groups, for example, treatment as usual (TAU), waiting list, attention control or community treatment by experts (CTBE). In studies that also included participants with other personality disorders (e.g. antisocial), we contacted the authors and requested disaggregated data. Studies were excluded with an arbitrary cut-off of \<66% of the participants having BPD, unless disaggregated data were provided. Also, studies were excluded that tested incomplete versions of specialized treatment, for example, studies that investigated only skills training instead of the full DBT program.

Search strategy {#section9-0004867418791257}
---------------

We searched PubMed, PsycINFO, CINAHL, EMBASE and CENTRAL from inception to the 13 November 2017 using terms for BPD, psychotherapy and RCTs ([Supplementary Material A](http://journals.sagepub.com/doi/suppl/10.1177/0004867418791257)). Subsequently, we searched the World Health Organization (WHO) International Clinical Trials Registry, reference lists of the included studies, excluded studies and previous reviews. We also contacted authors of (ongoing) studies to request additional data.

Assessment of bias {#section10-0004867418791257}
------------------

Included studies were assessed independently by two authors (M.O., R.V.) using the Cochrane Collaboration Risk of Bias Assessment Tool ([@bibr21-0004867418791257]). Disagreements were discussed and resolved by consensus. Each study was rated for risk of bias due to sequence generation, allocation concealment, masking of participants, assessors and providers, selective outcome reporting, incomplete data and allegiance effect. Risk of bias for each domain was rated as high (seriously weakens confidence in the effect estimate), low (unlikely to seriously alter the effect estimate) or unclear. Inter-rater reliability (IRR) of the initial risk of bias rating was examined with a two-way mixed model, absolute agreement and average-measures intra-class correlations (ICCs). Inter-rater agreement was satisfactory, with ICCs ranging from 0.545 to 0.770 with a mean of 0.649, median of 0.643 and standard deviation of 0.08.

Data management {#section11-0004867418791257}
---------------

Service user outcomes included overall BPD severity, single BPD symptoms (e.g. avoidance of abandonment, dysfunctional interpersonal patterns, identity disturbance, impulsivity, suicidal ideation, suicidal behavior, self-injurious behavior, affective instability, feelings of emptiness, anger and dissociative symptoms) and dropout. Continuous measures are listed in [Supplementary Material B](http://journals.sagepub.com/doi/suppl/10.1177/0004867418791257). We also extracted treatment format, number and length of sessions, age, sex, setting and study location. For each study, the important study characteristics are reported in [Table 1](#table1-0004867418791257){ref-type="table"}. If data were missing or could not be meta-analyzed, authors were contacted and additional data were requested.

###### 

Characteristics of the included studies.

![](10.1177_0004867418791257-table1)

  Study                                                  Country   Setting                           Mean age   \% Female   Intervention            *N* total per arm   Treatment completers %   Hours of contact per week                                                                                                                                                          Duration (weeks)   Follow-up (weeks)
  ------------------------------------------------------ --------- --------------------------------- ---------- ----------- ----------------------- ------------------- ------------------------ ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------ -------------------
  [@bibr39-0004867418791257]                             UK        Outpatients                       32.2       87.5        DBT vs TAU              40, 40              47.5, 100                3                                                                                                                                                                                  52                 --
  [@bibr16-0004867418791257]                             UK        Outpatients                       35.1       73          DBT vs TAU              26, 16              42.3, 93.8               3.5                                                                                                                                                                                52                 --
  Linehan et al. (1991)a                                 US        Outpatients                       18--45     100         DBT vs TAU              30, 31              73.3, 71                 NR                                                                                                                                                                                 52                 --
  Linehan et al. (1994)b                                 US        Outpatients                       26.7       100         DBT vs TAU              13, 13              100, 100                 NR                                                                                                                                                                                 52                 --
  [@bibr47-0004867418791257]                             NL        Outpatients                       34.9       100         DBT vs TAU              31, 33              77.4, 51.5               3.5                                                                                                                                                                                52                 --
  [@bibr29-0004867418791257]                             US        Outpatients                       29.3       100         DBT vs CTBE             52, 49              80.8, 57.1               3.5                                                                                                                                                                                52                 104
  [@bibr32-0004867418791257]                             CA        Outpatients                       30.4       86.8        DBT vs PPT (GPM)        90, 90              62.2, 61.1               5, 1                                                                                                                                                                               52                 156
  [@bibr46-0004867418791257]                             US        Outpatients                       22.0       79.2        DBT vs PPT (CCT)        12, 12              75, 50                   NR                                                                                                                                                                                 52                 --
  [@bibr8-0004867418791257]                              AUS       Outpatients                       42.5       100         DBT vs TAU              38, 35              52.6, 88.6               NR                                                                                                                                                                                 26                 --
  [@bibr24-0004867418791257]                             US        Outpatients                       35.0       100         DBT vs TAU              14, 14              71.4, 71.4               3                                                                                                                                                                                  26                 --
  [@bibr41-0004867418791257]/[@bibr6-0004867418791257]   DE        Hospitalized patients             35.9       100         DBT-PTSD vs TAU         17, 16              82, 81                   5.9                                                                                                                                                                                20                 --
  [@bibr30-0004867418791257]                             US        Outpatients                       30.3       100         DBT vs DBT-S vs DBT-I   33, 33, 33          75.8, 51.5, 60.6         1,^[a](#table-fn2-0004867418791257){ref-type="table-fn"}^ 0.7,^[a](#table-fn2-0004867418791257){ref-type="table-fn"}^ 0.6^[a](#table-fn2-0004867418791257){ref-type="table-fn"}^   52                 104
  [@bibr19-0004867418791257]                             US        Outpatients                       32.6       100         DBT vs DBT-PEP          9, 17               55.6, 59.9               3.5, 5.8                                                                                                                                                                           52                 65
  [@bibr13-0004867418791257]                             DE/AT     Outpatients                       27.3       100         TFP vs CTBE             52, 52              86.5, 75                 1.7                                                                                                                                                                                52                 --
  [@bibr9-0004867418791257]                              US        Outpatients                       30.9       92.2        TFP vs DBT vs SPT       31, 30, 29          74.1, 46.7, 75.9         1.7, 2.5, 0.8                                                                                                                                                                      52                 --
  [@bibr4-0004867418791257]                              UK        Partially hospitalized patients   31.8       57.9        MBT-PH vs TAU           22, 22              31.8, 86.4               6.5                                                                                                                                                                                78                 --
  [@bibr22-0004867418791257]                             DK        Outpatients                       29.2       95.5        MBT vs CTBE (SGP)       74, 37              52.7, 51.4               1.9                                                                                                                                                                                104                --
  [@bibr3-0004867418791257]                              UK        Outpatients                       31.3       79.9        MBT-out vs PPT (SCM)    71, 63              73.2, 74.6               6.5                                                                                                                                                                                78                 --
  [@bibr17-0004867418791257]                             NL        Outpatients                       30.6       93.0        ST vs TFP               45, 43              73.3, 48.8               1.7, 1.7                                                                                                                                                                           156                --
  [@bibr15-0004867418791257]                             US        Outpatients                       35.6       100         ST vs TAU               16, 16              100, 75                  1.5                                                                                                                                                                                35                 --
  [@bibr35-0004867418791257]                             NL        Outpatients                       32.0       96.8        ST vs ST + TTA          32, 30              78.1, 80                 1.5, 1.5                                                                                                                                                                           78                 --

TAU: treatment as usual; CCT: client-centered therapy; CTBE: community treatment by experts; PPT: protocolized psychological treatment; GPM: general psychiatric management according to APA guidelines; DBT: dialectical behavior therapy; MBT: metallization-based therapy; out: outpatient; PH: partially hospitalized; PTSD: post-traumatic stress disorder; SCM: structured clinical management; ST: schema(-focused) therapy; SGP: supported group psychotherapy; SPT: supportive psychotherapy; TTA: therapist telephone availability; TAU; treatment as usual; TFP: transference focused psychotherapy; I: individual therapy plus activities group; S: skills training plus case management; PEP: prolonged exposure protocol; NR: not reported; AUS: Australia; CA: Canada; DE: Germany; DK: Denmark; ES: Spain; UK: United Kingdom; NL: Netherlands; US: United States; AT: Austria.

Patients from the same trial

True amount of contact per week (mean for the whole group).

Statistical analysis {#section12-0004867418791257}
--------------------

For continuous outcomes, we calculated the standardized mean difference (SMD), Hedges' *g*, for between-group differences. SMDs were considered small (0.2 ⩽ SMD \< 0.5), medium (0.5 ⩽ SMD \< 0.8) or large (SMD ⩾ 0.8) ([@bibr10-0004867418791257]). For dichotomous outcomes, we calculated the risk ratio (RR) for events. If continuous and dichotomous effect estimates were reported for an outcome, we transformed RRs into SMDs so that effect estimates could be pooled. All outcomes are reported with 95% confidence intervals (CIs). Overall effects were calculated using random effects models. Continuous effects were weighted by the inverse of variance; dichotomous effects were weighted using the Mantel--Haenszel method ([@bibr21-0004867418791257]).

Statistical heterogeneity was assessed by visual inspection of forest plots, by performing the χ^2^ test (assessing the *p* value), and by calculating the *I*^2^ statistic, which describes the percentage of observed heterogeneity that would not be expected by chance. If the *p* value was less than 0.10 and *I*^2^ exceeded 50%, we considered heterogeneity to be substantial. Meta-analyses of comparisons and subgroups were conducted using Review Manager (RevMan) 5.3 ([@bibr37-0004867418791257]). Confidence in the effect estimates were assessed by M.O. and M.L.M.H. using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) method ([@bibr18-0004867418791257]), which is a structured assessment of the quality of evidence attending to the following factors: risk of bias, inconsistency, indirectness, imprecision and publication bias. Outcomes can be 'downgraded' on the basis of these factors resulting in 'high', 'moderate', 'low' or 'very low' confidence in the effect estimate.

Results {#section13-0004867418791257}
=======

Study flow {#section14-0004867418791257}
----------

Of 1013 potentially relevant citations, we retrieved papers of 29 distinct studies, which were assessed for inclusion ([Figure 1](#fig1-0004867418791257){ref-type="fig"}). Of these, nine studies were excluded due to several reasons: the duration of the intervention was not sufficient (\<16 weeks of therapy), no individual treatment component was present to be regarded as a specialized psychotherapy, \<66% of the participants were diagnosed with BPD, and no RCT. In total, 63 papers of 20 studies were, therefore, included, which were published between 2014 and 2015.

![Study selection.](10.1177_0004867418791257-fig1){#fig1-0004867418791257}

Study characteristics {#section15-0004867418791257}
---------------------

Characteristics of each study are presented in [Table 1](#table1-0004867418791257){ref-type="table"}. Included studies randomized 1375 participants, ranging from 24 to 180 per study. Studies were conducted in North America (*k* = 10), United Kingdom (*k* = 4), continental Europe (*k* = 5) and Australia (*k* = 1). Participants were mostly treated in outpatient settings (*k* = 18); only one study was conducted in an inpatient setting, and in another participants were partially hospitalized. In almost all studies a structured diagnostic interview was used to assess and establish the presence of BPD, most commonly with a version of the Structured Clinical Interview for DSM Personality Disorders (SCID-II), one study ([@bibr15-0004867418791257]) did not and used the diagnostic interview for borderline patients--revised (DIB-R; [@bibr48-0004867418791257]). Only 4 of the 20 studies had follow-up data, ranging from 65 to 156 weeks. Across all studies, the median of the mean age of participants was 32 years (range, 22--43) and almost all participants were female (mean = 93%, range = 58--100%).

Interventions {#section16-0004867418791257}
-------------

The included studies investigated a variety of interventions ([Supplementary Material C](http://journals.sagepub.com/doi/suppl/10.1177/0004867418791257)). A team of four clinical experts independently classified treatments, and disagreements were resolved in a consensus meeting. This process resulted in 10 comparisons for meta-analysis. Specialized psychotherapies were compared with TAU, with CTBE and with protocolized psychological treatment, which comprised general psychiatric management (GPM), structured clinical management (SCM) and client-centered therapy (CCT). The other seven comparisons were head-to-head comparisons, of which two compared different types of specialized therapies (DBT vs TFP and ST vs TFP). Two other comparisons investigated the efficacy of add-on interventions (ST with or without therapist telephone availability; DBT with or without prolonged exposure). Finally, in three comparisons, DBT was compared with two interventions containing DBT elements (one with only individual therapy plus group activities and the other with only group skills training and case management); these semi-DBT interventions were compared with each other in the final comparison.

Risk of bias {#section17-0004867418791257}
------------

Risk of bias per study is presented in [Figure 2](#fig2-0004867418791257){ref-type="fig"}, and two references are on the same study ([@bibr28-0004867418791257], [@bibr31-0004867418791257]). No studies were at high risk of bias for random sequence generation; however, the method of randomization was not reported in four studies. Allocation concealment was unclear in 7 studies and had a low risk in 14 studies. Masking of participants and providers in studies of psychological interventions is impossible and therefore all were at high risk of bias. Four of the studies did not have masked assessors and these were considered to be at high risk of bias. Regarding incomplete outcome data, seven were at high risk of bias because of the number (more than 10%) of missing cases or because missing cases were excluded from the analyses. Six studies were at high risk of allegiance bias, because the developers of the treatment protocol were also involved in the research investigating the efficacy.

![Risk of bias summary.](10.1177_0004867418791257-fig2){#fig2-0004867418791257}

Reporting bias {#section18-0004867418791257}
--------------

There was no high risk of selective outcome reporting. Only four studies were prospectively registered; all others were at unclear risk of bias. Risk of publication bias could not be assessed by means of funnel plots because there were too few studies for all comparisons.

Overall quality of the evidence {#section19-0004867418791257}
-------------------------------

All outcomes were downgraded due to imprecision of the effect estimates (wide CIs because of few participants or events). Effect estimates for overall BPD severity and self-injury following specialized therapy were of moderate quality, as rated with the GRADE method. Most other evidence was rated low or very low. A small number of studies also reported follow-up data; overall these outcomes were of low quality.

Quantitative data synthesis {#section20-0004867418791257}
---------------------------

Effect estimates of the meta-analyses suggest that specialized therapies are associated with improvement in overall BPD severity and with a reduction in self-injury ([Tables 2](#table2-0004867418791257){ref-type="table"} and [3](#table3-0004867418791257){ref-type="table"}). All outcomes are summarized for each comparison and subgroup in [Supplementary Material D and E](http://journals.sagepub.com/doi/suppl/10.1177/0004867418791257), including reasons for downgrading. Very low quality outcomes can be found in the supplementary material, too, but we will not report on all of these in the treatment results described below.

###### 

Outcomes at post-treatment.

![](10.1177_0004867418791257-table2)

  Outcome                                                                                                             Sub-analysis                                               Trials (reference)                                                                                                                             *N*            Effect size        \[95% CI\]           Heterogeneity (*I*²)   Intervention length (weeks)   Quality (GRADE)
  ------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------- -------------- ------------------ -------------------- ---------------------- ----------------------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  SMD below zero or a RR below 1 means the treatment (condition) was more effective than the comparator (condition)                                                                                                                                                                                                                                                                                                                         
  *1. Specialized psychotherapy versus treatment as usual (TAU)*                                                                                                                                                                                                                                                                                                                                                                            
  Overall BPD severity                                                                                                Total                                                      4                                                                                                                                              151            SMD = --0.75       \[--1.30, --0.19\]   58%                    20--52                        Low^[b](#table-fn6-0004867418791257){ref-type="table-fn"},[d](#table-fn8-0004867418791257){ref-type="table-fn"}^
  DBT                                                                                                                 ([@bibr39-0004867418791257]; [@bibr24-0004867418791257])   90                                                                                                                                             SMD = --0.36   \[--0.78, 0.05\]   0%                   26--52                                               
                                                                                                                      DBT-PTSD                                                   ([@bibr41-0004867418791257])                                                                                                                   33             SMD = --0.85       \[--1.57, --0.13\]   N/A                    20                            
                                                                                                                      SFT-Group                                                  ([@bibr15-0004867418791257])                                                                                                                   28             SMD = --1.66       \[--2.54, --0.78\]   N/A                    35                            
  Self-injury                                                                                                         Total                                                      7                                                                                                                                              314            SMD = --0.33       \[--0.57, --0.09\]   0%                     26--78                        Moderate^[d](#table-fn8-0004867418791257){ref-type="table-fn"}^
                                                                                                                      DBT                                                        ([@bibr16-0004867418791257]; [@bibr24-0004867418791257]; [@bibr28-0004867418791257]; [@bibr39-0004867418791257]; [@bibr47-0004867418791257])   225            SMD = --0.40       \[--0.66, --0.13\]   0%                     26--52                        Moderate^[d](#table-fn8-0004867418791257){ref-type="table-fn"}^
                                                                                                                                                                                 ([@bibr8-0004867418791257])                                                                                                                    51             RR = 1.11          \[0.78, 1.57\]       N/A                    26                            
                                                                                                                      MBT-PH                                                     ([@bibr2-0004867418791257])                                                                                                                    38             RR = 0.44          \[0.24, 0.81\]       N/A                    78                            
  Dropout                                                                                                             Total                                                      10                                                                                                                                             486            RR = 1.54          \[0.70, 3.38\]       76%                    20--78                        Low^[b](#table-fn6-0004867418791257){ref-type="table-fn"},[d](#table-fn8-0004867418791257){ref-type="table-fn"}^
  *2. Specialized psychotherapy versus community treatment by experts (CTBE)*                                                                                                                                                                                                                                                                                                                                                               
  Overall BPD severity                                                                                                Total                                                      2                                                                                                                                              170            SMD = --0.47       \[--0.78, --0.16\]   0%                     52--104                       Moderate^[d](#table-fn8-0004867418791257){ref-type="table-fn"}^
  MBT                                                                                                                 ([@bibr22-0004867418791257])                               66                                                                                                                                             SMD = --0.33   \[--0.84, 0.17\]   N/A                  104                                                  
                                                                                                                      TFP                                                        ([@bibr13-0004867418791257])                                                                                                                   104            SMD = --0.55       \[--0.95, --0.16\]   N/A                    52                            
  Self-injury                                                                                                         TFP                                                        ([@bibr13-0004867418791257])                                                                                                                   104            RR = 1.09          \[0.84, 1.40\]       N/A                    52                            Low^[d](#table-fn8-0004867418791257){ref-type="table-fn"}^
  Dropout                                                                                                             Total                                                      3                                                                                                                                              316            RR = 0.62          \[0.39, 0.99\]       73%                    52--104                       Low^[b](#table-fn6-0004867418791257){ref-type="table-fn"},[d](#table-fn8-0004867418791257){ref-type="table-fn"}^
  *3. Specialized psychotherapy versus protocolized psychological treatment*                                                                                                                                                                                                                                                                                                                                                                
  Overall BPD severity                                                                                                DBT vs GPM                                                 ([@bibr32-0004867418791257])                                                                                                                   180            SMD = --0.04       \[--0.33, 0.25\]     N/A                    52                            Low^[d](#table-fn8-0004867418791257){ref-type="table-fn"}^
  Self-injury                                                                                                         Total                                                      2                                                                                                                                              122            RR = 0.80          \[0.42, 1.55\]       80%                    52--78                        Very low^[b](#table-fn6-0004867418791257){ref-type="table-fn"},[c](#table-fn7-0004867418791257){ref-type="table-fn"},[d](#table-fn8-0004867418791257){ref-type="table-fn"}^
                                                                                                                      DBT vs GPM                                                 ([@bibr32-0004867418791257])                                                                                                                   177            RR = 1.09          \[0.79, 1.50\]       N/A                    52                            Low^[d](#table-fn8-0004867418791257){ref-type="table-fn"}^
                                                                                                                      MBT-PH or out vs SCM                                       ([@bibr4-0004867418791257])                                                                                                                    134            RR = 0.56          \[0.34, 0.92\]       N/A                    78                            Moderate^[d](#table-fn8-0004867418791257){ref-type="table-fn"}^
  Self-injury                                                                                                         DBT vs CCT                                                 ([@bibr46-0004867418791257])                                                                                                                   24             SMD = --1.28       \[--2.17, --0.38\]   N/A                    52                            Low^[d](#table-fn8-0004867418791257){ref-type="table-fn"}^
  Dropout                                                                                                             Total                                                      4                                                                                                                                              265            RR = 1.06          \[0.81, 1.40\]       0%                     52--78                        Low^[c](#table-fn7-0004867418791257){ref-type="table-fn"},[d](#table-fn8-0004867418791257){ref-type="table-fn"}^
  *4. Dialectical behavior therapy vs transference-focused psychotherapy (TFP)*                                                                                                                                                                                                                                                                                                                                                             
  Suicidal behavior                                                                                                   DBT vs TFP                                                 ([@bibr9-0004867418791257])                                                                                                                    39             SMD = 0.13         \[--0.51, 0.76\]     N/A                    52                            Very low^[a](#table-fn5-0004867418791257){ref-type="table-fn"},[d](#table-fn8-0004867418791257){ref-type="table-fn"}^
  Dropout                                                                                                             DBT vs TFP                                                 ([@bibr9-0004867418791257])                                                                                                                    39             RR = 2.07          \[1.04, 4.10\]       N/A                    52                            Very low^[a](#table-fn5-0004867418791257){ref-type="table-fn"},[d](#table-fn8-0004867418791257){ref-type="table-fn"}^
  *5. Schema(-focused) therapy (ST) vs transference-focused psychotherapy (TFP)*                                                                                                                                                                                                                                                                                                                                                            
  Overall BPD severity                                                                                                ST vs TFP                                                  ([@bibr17-0004867418791257])                                                                                                                   86             SMD = --0.45       \[--0.87, --0.02\]   N/A                    156                           Low^[d](#table-fn8-0004867418791257){ref-type="table-fn"}^
  Dropout                                                                                                             ST vs TFP                                                  ([@bibr17-0004867418791257])                                                                                                                   88             RR = 0.52          \[0.30, 0.92\]       N/A                    156                           Low^[d](#table-fn8-0004867418791257){ref-type="table-fn"}^
  *6. Schema(-focused) therapy (ST) vs ST + TTA*                                                                                                                                                                                                                                                                                                                                                                                            
  Overall BPD severity                                                                                                ST vs ST + TTA                                             ([@bibr35-0004867418791257])                                                                                                                   61             SMD = 0.13         \[--0.51, 0.76\]     N/A                    78                            Low^[d](#table-fn8-0004867418791257){ref-type="table-fn"}^
  Dropout                                                                                                             ST vs ST + TTA                                             ([@bibr35-0004867418791257])                                                                                                                   62             RR = 0.91          \[0.35, 2.41\]       N/A                    78                            Low^[d](#table-fn8-0004867418791257){ref-type="table-fn"}^
  *7. DBT vs DBT prolonged exposure protocol (DBT-PEP)*                                                                                                                                                                                                                                                                                                                                                                                     
  Self-injury                                                                                                         DBT vs DBT-PEP                                             ([@bibr19-0004867418791257])                                                                                                                   18             SMD = 0.05         \[--0.93, 1.03\]     N/A                    52                            Low^[d](#table-fn8-0004867418791257){ref-type="table-fn"}^
  Dropout                                                                                                             DBT vs DBT-PEP                                             ([@bibr19-0004867418791257])                                                                                                                   18             RR = 1.35          \[0.60, 3.05\]       N/A                    52                            Low^[d](#table-fn8-0004867418791257){ref-type="table-fn"}^
  *8. DBT vs DBT-S (skills training plus case management)*                                                                                                                                                                                                                                                                                                                                                                                  
  Self-injury                                                                                                         DBT vs DBT-S                                               ([@bibr30-0004867418791257])                                                                                                                   66             SMD = 0.02         \[--0.47, 0.50\]     N/A                    52                            Low^[d](#table-fn8-0004867418791257){ref-type="table-fn"}^
  Self-injury                                                                                                         DBT vs DBT-S                                               ([@bibr30-0004867418791257])                                                                                                                   66             RR = 1.06          \[0.69, 1.62\]       N/A                    52                            Low^[d](#table-fn8-0004867418791257){ref-type="table-fn"}^
  Dropout                                                                                                             DBT vs DBT-S                                               ([@bibr30-0004867418791257])                                                                                                                   66             RR = 0.50          \[0.25, 1.01\]       N/A                    52                            Low^[d](#table-fn8-0004867418791257){ref-type="table-fn"}^
  *9. DBT vs DBT-I (individual therapy plus activities group)*                                                                                                                                                                                                                                                                                                                                                                              
  Self-injury                                                                                                         DBT vs DBT-I                                               ([@bibr30-0004867418791257])                                                                                                                   66             SMD = --0.39       \[--0.88, 0.09\]     N/A                    52                            Low^[d](#table-fn8-0004867418791257){ref-type="table-fn"}^
  Self-injury                                                                                                         DBT vs DBT-I                                               ([@bibr30-0004867418791257])                                                                                                                   66             RR = 0.90          \[0.61, 1.34\]       N/A                    52                            Low^[d](#table-fn8-0004867418791257){ref-type="table-fn"}^
  Dropout                                                                                                             DBT vs DBT-I                                               ([@bibr30-0004867418791257])                                                                                                                   66             RR = 0.62          \[0.29, 1.29\]       N/A                    52                            Low^[d](#table-fn8-0004867418791257){ref-type="table-fn"}^
  *10. DBT-I vs DBT-S*                                                                                                                                                                                                                                                                                                                                                                                                                      
  Self-injury                                                                                                         DBT-I vs DBT-S                                             ([@bibr30-0004867418791257])                                                                                                                   66             SMD = 0.39         \[--0.10, 0.88\]     N/A                    52                            Low^[d](#table-fn8-0004867418791257){ref-type="table-fn"}^
  Self-injury                                                                                                         DBT-I vs DBT-S                                             ([@bibr30-0004867418791257])                                                                                                                   66             RR = 1.17          \[0.78, 1.75\]       N/A                    52                            Low^[d](#table-fn8-0004867418791257){ref-type="table-fn"}^
  Dropout                                                                                                             DBT-I vs DBT-S                                             ([@bibr30-0004867418791257])                                                                                                                   66             RR = 0.81          \[0.47, 1.41\]       N/A                    52                            Low^[d](#table-fn8-0004867418791257){ref-type="table-fn"}^

GRADE: Grading of Recommendations Assessment, Development and Evaluation; BPD: borderline personality disorder; DBT: dialectical behavior therapy; PTSD: post-traumatic stress disorder; SFT: schema-focused therapy; MBT: mentalization-based treatment; PH: partially hospitalized; GPM: general psychiatric management according to APA guidelines; SCM: structured clinical management; CCT: client-centered therapy; TTA: therapist telephone availability; N/A: not applicable; SMD: standardized mean difference; RR: risk ratio.
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###### 

Outcomes at follow-up.

![](10.1177_0004867418791257-table3)

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Outcome                                                                                                             Sub-analysis       Trials (reference)             *N*   Effect Size    \[95% CI\]         Heterogeneity\   Intervention length (weeks)   Quality (GRADE)
                                                                                                                                                                                                                (*I*^2^)                                       
  ------------------------------------------------------------------------------------------------------------------- ------------------ ------------------------------ ----- -------------- ------------------ ---------------- ----------------------------- -------------------------------------------------------------------------------------------------------------------------
  SMD below zero or a RR below 1 means the treatment (condition) was more effective than the comparator (condition)                                                                                                                                            

  *2. Specialized psychotherapy vs community treatment by experts (CTBE)*                                                                                                                                                                                      

  Overall BPD severity                                                                                                MBT                ([@bibr22-0004867418791257])   54    SMD = --0.12   \[--0.70, 0.47\]   N/A              182                           Very low^[a](#table-fn11-0004867418791257){ref-type="table-fn"},[d](#table-fn14-0004867418791257){ref-type="table-fn"}^

  *3. Specialized psychotherapy vs protocolized psychological treatment*                                                                                                                                                                                       

  Overall BPD severity                                                                                                DBT vs GPM         ([@bibr32-0004867418791257])   180   SMD = 0.27     \[--0.02, 0.57\]   N/A              156                           Low^[d](#table-fn14-0004867418791257){ref-type="table-fn"}^

  Self-injury                                                                                                         DBT vs GPM         ([@bibr32-0004867418791257])   177   RR = 0.81      \[0.50, 1.30\]     N/A              156                           Low^[d](#table-fn14-0004867418791257){ref-type="table-fn"}^

  *7. DBT vs DBT prolonged exposure protocol (DBT-PEP)*                                                                                                                                                                                                        

  Self-injury                                                                                                         DBT vs DBT-PEP     ([@bibr19-0004867418791257])   18    SMD = --0.28   \[--1.26, 0.71\]   N/A              65                            Low^[d](#table-fn14-0004867418791257){ref-type="table-fn"}^

  *8. DBT vs DBT-S (skills training plus case management)*                                                                                                                                                                                                     

  Self-injury                                                                                                         DBT versus DBT-S   ([@bibr30-0004867418791257])   66    SMD = --0.09   \[--0.58, 0.39\]   N/A              104                           Low^[d](#table-fn14-0004867418791257){ref-type="table-fn"}^

  Self-injury                                                                                                         DBT versus DBT-S   ([@bibr30-0004867418791257])   66    RR = 1.00      \[0.59, 1.70\]\]   N/A              104                           Low^[d](#table-fn14-0004867418791257){ref-type="table-fn"}^

  *9. DBT vs DBT-I (individual therapy plus activities group)*                                                                                                                                                                                                 

  Self-injury                                                                                                         DBT vs DBT-I       ([@bibr30-0004867418791257])   66    SMD = --0.34   \[--0.82, 0.15\]   N/A              104                           Low^[d](#table-fn14-0004867418791257){ref-type="table-fn"}^

  Self-injury                                                                                                         DBT vs DBT-I       ([@bibr30-0004867418791257])   66    RR = 1.15      \[0.66, 2.03\]     N/A              104                           Low^[d](#table-fn14-0004867418791257){ref-type="table-fn"}^

  *10. DBT-I vs DBT-S*                                                                                                                                                                                                                                         

  Self-injury                                                                                                         DBT-I vs DBT-S     ([@bibr30-0004867418791257])   66    SMD = 0.24     \[--0.24, 0.72\]   N/A              104                           Low^[d](#table-fn14-0004867418791257){ref-type="table-fn"}^

  Self-injury                                                                                                         DBT-I vs DBT-S     ([@bibr30-0004867418791257])   66    RR = 0.87      \[0.49, 1.52\]     N/A              104                           Low^[d](#table-fn14-0004867418791257){ref-type="table-fn"}^
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

GRADE: Grading of Recommendations Assessment, Development and Evaluation; BPD: borderline personality disorder; MBT: metallization-based therapy; DBT: dialectical behavior therapy; GPM: general psychiatric management according to APA guidelines; N/A: not applicable; SMD: standardized mean difference; RR: risk ratio.
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### Specialized psychotherapies versus TAU {#section21-0004867418791257}

Nine RCTs (*n* = 524) compared specialized psychotherapies with TAU. Studies investigated DBT ([@bibr8-0004867418791257]; [@bibr16-0004867418791257]; [@bibr24-0004867418791257]; [@bibr28-0004867418791257], [@bibr31-0004867418791257]; [@bibr39-0004867418791257]; [@bibr47-0004867418791257]), DBT with trauma focused interventions (DBT-PTSD; [@bibr6-0004867418791257]; [@bibr41-0004867418791257]), MBT ([@bibr2-0004867418791257]) and ST ([@bibr15-0004867418791257]).

Low-quality evidence was found for specialized psychotherapies being associated with a medium effect on reducing the overall severity of BPD (*k* = 4; *n* = 151; SMD = --0.75 \[95% CI: --1.30, --0.19\]; for forest plot see [Supplementary Material F](http://journals.sagepub.com/doi/suppl/10.1177/0004867418791257); [@bibr6-0004867418791257]; [@bibr15-0004867418791257]; [@bibr24-0004867418791257]; [@bibr39-0004867418791257]; [@bibr41-0004867418791257]) and a large effect on suicidal behavior (*k* = 1; *n* = 38; RR = 0.08 \[95% CI: 0.01, 0.58\]) at post-treatment ([@bibr2-0004867418791257]). Seven studies (*n* = 314) reported moderate quality evidence that specialized psychotherapies were associated with a small effect on a reduction in self-injury at post-treatment (SMD = --0.33 \[95% CI −0.57, −0.09\]; [@bibr16-0004867418791257]; [@bibr24-0004867418791257]; [@bibr28-0004867418791257], [@bibr31-0004867418791257]; [@bibr39-0004867418791257]; [@bibr47-0004867418791257]). However, for effects on anger ([@bibr16-0004867418791257]; [@bibr24-0004867418791257]; [@bibr28-0004867418791257], [@bibr31-0004867418791257]) and risk of dropout, the data were inconclusive ([@bibr2-0004867418791257]; [@bibr6-0004867418791257]; [@bibr8-0004867418791257]; [@bibr15-0004867418791257]; [@bibr16-0004867418791257]; [@bibr24-0004867418791257]; [@bibr28-0004867418791257], [@bibr31-0004867418791257]; [@bibr39-0004867418791257]; [@bibr41-0004867418791257]; [@bibr47-0004867418791257]). For all other outcomes (e.g. dysfunctional interpersonal patterns, dissociations, affective instability and impulsivity), the quality was very low. The undertaken studies did not report follow-up results.

### Specialized psychotherapies versus CTBE {#section22-0004867418791257}

Three RCTs (*n* = 391) compared specialized psychotherapies with CTBE. Studies investigated DBT ([@bibr29-0004867418791257]), MBT ([@bibr22-0004867418791257]) and TFP ([@bibr13-0004867418791257]).

Two studies (*n* = 170) reported moderate quality evidence that specialized psychotherapies were associated with a medium effect on reducing the overall severity of BPD at post-treatment (SMD = --0.47 \[95% CI: --0.78, --0.16\]; for forest plot see [Supplementary Material F](http://journals.sagepub.com/doi/suppl/10.1177/0004867418791257); [@bibr13-0004867418791257]; [@bibr22-0004867418791257]). Also, there was a 38% lower risk of dropout from the specialized psychotherapies group (*k* = 3; *n* = 326; [@bibr13-0004867418791257]; [@bibr22-0004867418791257]; [@bibr29-0004867418791257]). There was low-quality evidence of no difference in effect between specialized psychotherapies and CTBE on suicidal behavior (*k* = 2; *n* = 193; SMD = --0.18 \[95% CI: --0.52, 0.15\]; [@bibr13-0004867418791257]; [@bibr29-0004867418791257]) and self-injury (*k* = 1; *n* = 104; RR = 1.09 \[95% CI: 0.84, 1.40\]), although the CI was compatible with both a reduction and increase in effect ([@bibr13-0004867418791257]). For the outcome of dysfunctional interpersonal patterns, the quality was very low ([@bibr22-0004867418791257]). Only the study of MBT ([@bibr22-0004867418791257]) reported follow-up results on overall BPD severity and dysfunctional interpersonal patterns, but the quality of effect estimates was considered very low.

### Specialized psychotherapies versus protocolized psychological treatment {#section23-0004867418791257}

Four RCTs (*n* = 401) compared specialized psychotherapies with protocolized psychological treatment ([@bibr3-0004867418791257]; [@bibr9-0004867418791257]; [@bibr32-0004867418791257]; [@bibr46-0004867418791257]); one compared MBT with SCM ([@bibr3-0004867418791257]), one compared DBT with CCT ([@bibr46-0004867418791257]), one compared DBT with GPM ([@bibr32-0004867418791257]) and one compared DBT and TFP with supportive psychotherapy (SPT) ([@bibr9-0004867418791257]).

At post-treatment the data were of low quality and inconclusive on the outcomes of overall severity of BPD (for forest plot see [Supplementary Material F](http://journals.sagepub.com/doi/suppl/10.1177/0004867418791257)), suicidal behavior, dissociation, anger, affective instability and dropout. For all other outcomes (e.g. self-injury, dysfunctional interpersonal patterns and impulsivity), the quality was very low.

At follow-up, moderate quality evidence was found for a small effect of protocolized psychological treatment on anger (*k* = 1; *N* = 180; SMD = 0.37 \[95% CI: 0.07, 0.66\]). Low-quality evidence was inconclusive for the following outcomes: overall BPD severity, suicidal behavior, self-injury, dysfunctional interpersonal patterns, affective instability and impulsivity.

### Head-to-head comparison of specialized psychotherapies {#section24-0004867418791257}

Two RCTs (*n* = 178) compared two specialized psychotherapies. TFP was compared with DBT in one study ([@bibr9-0004867418791257]) and with ST in another ([@bibr17-0004867418791257]).

At post-treatment one study (*n* = 86) reported low-quality results of a medium effect of ST (compared with TFP) on reducing the overall severity of BPD (SMD = --0.45 \[95% CI: --0.87, --0.02\]), and there was also 48% less risk of dropout ([@bibr17-0004867418791257]). In another study (*n* = 39), there were very low quality and inconclusive effect estimates on suicidal behavior, anger and impulsivity when DBT was compared with TFP. However, participants treated with TFP had a two times lower risk of dropout ([@bibr9-0004867418791257]).

### Adjusted specialized psychotherapies versus the original intervention {#section25-0004867418791257}

Three RCTs (*n* = 187) compared modified versions of a specialized psychotherapy to an original version. The following modified psychotherapies were investigated: DBT with a prolonged exposure protocol ([@bibr19-0004867418791257]), DBT consisting only of individual therapy plus an activities group (DBT-I; [@bibr30-0004867418791257]), DBT consisting only of group skills training and case management (DBT-S; [@bibr30-0004867418791257]) and ST with therapist telephone availability ([@bibr35-0004867418791257]).

At post-treatment, the effect estimates were of low quality and inconclusive in all comparisons. This was also the case at follow-up, except for the outcome of suicidal behavior where a medium effect was found for DBT compared with DBT-I (*k* = 1; *N* = 66; SMD = --0.64 \[95% CI: --1.14, --0.14\]; [@bibr30-0004867418791257]).

### Specialized psychotherapies versus TAU and CTBE combined (post hoc analysis) {#section26-0004867418791257}

As CTBE can be seen as a special form of TAU (i.e. psychotherapy-as-usual provided by community experts), and due to the similarities of the two meta-analyses involving TAU and CTBE, we conducted a post hoc analysis on BPD severity (see [Figure 3](#fig3-0004867418791257){ref-type="fig"}) by combining results of the six studies comparing specialized psychotherapies with TAU or CTBE (*N* = 321; *I*² = 39%; [@bibr13-0004867418791257]; [@bibr15-0004867418791257]; [@bibr22-0004867418791257]; [@bibr24-0004867418791257]; [@bibr39-0004867418791257]; [@bibr41-0004867418791257]). A medium effect with moderate quality evidence (SMD = --0.59 \[95% CI: --0.90, --0.28\]) on reducing the severity of BPD was found in favor of specialized psychotherapies.

![Forest plot of post hoc analysis on overall BPD severity at post-treatment.](10.1177_0004867418791257-fig3){#fig3-0004867418791257}

Discussion {#section27-0004867418791257}
==========

To our knowledge, this is the first comprehensive review (*N* = 1375) of specialized psychotherapies (DBT, MBT, TFP and ST) for the treatment of BPD in adults since [@bibr42-0004867418791257] reviewed the literature up to 2010. Although [@bibr11-0004867418791257] updated the evidence until the end of 2015, the review did not focus on the specific effectiveness of specialized psychotherapies and did not investigate the comparative effectiveness of psychotherapies. Moreover, they did not GRADE the outcomes, whereas the certainty of evidence per outcome influences the relevance for clinical practice. Our review included some relevant studies ([@bibr6-0004867418791257]; [@bibr9-0004867418791257]; [@bibr16-0004867418791257]; [@bibr17-0004867418791257]; [@bibr19-0004867418791257]; [@bibr30-0004867418791257]; [@bibr35-0004867418791257]; [@bibr41-0004867418791257]) that were missing in the meta-analysis of [@bibr11-0004867418791257] and, by pooling the studies on specialized psychotherapies together and GRADEing the evidence on treatment outcomes, we created a stronger and transparent evidence base for treatment effects. In addition, we investigated the effectiveness of individual specialized psychotherapies by including studies with head-to-head comparisons.

The evidence suggests that these specialized psychotherapies, which have been designed for people with BPD, are more effective than TAU and CTBE. The post hoc analysis in which studies comparing specialized psychotherapies with TAU or CTBE were combined (*N* = 321; *I*^2^ = 39%) confirms this and moderate quality evidence of a medium effect on reducing the severity of BPD was found in favor of specialized psychotherapies. Furthermore, moderate quality effects were found for specialized psychotherapies on reducing self-injury. Another important benefit of specialized psychotherapies is that they are generally well tolerated. Participants had 38% less chance of dropout when compared with CTBE and there was no significant difference in dropout when compared with TAU.

Interestingly, specialized psychotherapies compared to protocolized psychological treatment show no significant differences on almost any outcome, although the quality of the evidence was mostly low to very low due to a significant amount of heterogeneity. Subgroup analysis provided moderate quality positive effects of MBT on suicidal behavior, self-injury and dysfunctional interpersonal patterns in comparison with SCM. In the second subgroup, DBT was superior to CCT on reducing suicidal behavior, self-injury and dissociation/psychoticism, but the quality of the evidence was low. However, DBT was not superior when compared with GPM. Moderate quality evidence also showed that GPM was statistically more effective on anger at follow-up. In another comparison, when specialized therapies were compared with each other (head-to-head), the results were mostly inconclusive. Only one statistically significant difference of low-quality evidence was found: ST was more effective than TFP on overall BPD severity and on treatment dropout.

It is possible to criticize our approach of aggregating specialized psychotherapies because of the differences between these psychotherapies. However, the specialized therapies share commonalities, including a theoretical framework connecting etiological and maintenance factors to therapeutic techniques, a BPD-specific rationale for patients and therapists, advice for therapists (e.g. how to respond to problematic behaviors) and a structured program for patients. By meta-analyzing the results of all specialized psychotherapies, the result could have been inconsistent (statistical heterogeneity), but this was not the case for most outcomes.

In conclusion, specialized therapies are more effective than TAU and CTBE, but it is not clear which one works better for whom and if they are more effective than protocolized psychological treatment. Moreover, it cannot be concluded from this analysis whether there might be a difference in effectiveness or dropout between specialized psychotherapies, let alone whether they are statistically equivalent (for which large *N*s are needed).

Implications for practice {#section28-0004867418791257}
-------------------------

The current meta-analysis leads us to recommend the provision of specialized psychotherapies in the treatment of outpatients with BPD to reduce their symptoms. The findings of our review are important because in actual practice most patients are not often treated with prolonged specialized psychotherapies ([@bibr20-0004867418791257]). Pharmacological treatment has not been found to be effective in reducing the overall severity of BPD ([@bibr25-0004867418791257]).

Although we cannot conclude this directly from the meta-analysis, we hypothesize that protocolized psychological treatment (e.g. GPM) could be more feasible in community health teams for less complex BPD. For more severe patients, specialized psychotherapies are warranted ([@bibr1-0004867418791257]). Service users could be informed about the different specialized psychotherapies that are available at a center to help choose between them. Service user preference should be a priority because, in general, patient-preferred treatment leads to better outcomes and lower dropout ([@bibr33-0004867418791257]; [@bibr43-0004867418791257]). In addition, it could improve the therapeutic alliance, also a contributor to positive treatment outcomes ([@bibr1-0004867418791257]). A decision about which specialized psychotherapy to provide could be made on the basis of costs. In a recent economic evaluation ([@bibr7-0004867418791257]), it was concluded that most specialized psychotherapies (DBT and ST) were cost saving when compared with TAU, and there were also indications that ST was more cost-saving than TFP.

Directions for future research {#section29-0004867418791257}
------------------------------

First, the evidence base should be strengthened by undertaking more well-powered RCTs into existing treatments (e.g. replication studies) instead of (underpowered) (R)CTs of new treatments. Furthermore, there are indications that the difference in effectiveness between protocolized and specialized psychotherapies is spurious for people with less severe BPD. Thus, future research should focus on testing this issue further, preferably using a large RCT comparing these two types of treatments and deducing the difference in effect on service users with severe or less severe BPD problems, also investigating the relative cost effectiveness. Second, it remains unclear which specialized psychotherapy is more effective and whether there are differences on individual BPD outcomes between the specialized treatments. This should therefore be investigated. Further research should be undertaken to investigate the effects of specialized therapies for inpatients, because providing these interventions in this setting is common in some countries and treating people with BPD in hospital for a long period of time may do more harm than good ([@bibr27-0004867418791257]). Another important point to potentially improve effectiveness and reduce costs is that further research should support the development of tailored specialized therapies for specific BPD profiles. This could be achieved by delineating the effective ingredients from these interventions. [@bibr35-0004867418791257] and [@bibr30-0004867418791257] have investigated effective elements by eliminating certain aspects of specialized therapies and comparing the 'stripped' version with the original protocol. No differences in effect were found, although the quality of the evidence was low. Also a recent meta-analysis on the treatment of BPD found that psychological interventions that were offered more than once a week and those that included group sessions had significantly greater improvements in social functioning and reduction in self-injury and depression than those that consisted of one session per week or only individual sessions ([@bibr38-0004867418791257]).

We have some methodological recommendations that can be made to help build solid, reliable and transparent (meta-analytic) evidence. First, considering that the majority of the RCTs were not registered, the risk of bias in the overall body of evidence could and should be reduced by prospective registration of future studies in established trial registers. Moreover, this advice applies to the whole field of research into non-pharmacological interventions, because unregistered studies are not uncommon ([@bibr12-0004867418791257]). Risk of bias should also be reduced by studies performed by independent investigators; in our review, we noticed that some study authors were founders of the study protocols, which could lead to allegiance bias ([@bibr14-0004867418791257]) and thus to an overestimation of the results. Further steps to prevent bias are mixed model analyses to account for study dropouts, and independent replication studies. Second, with regard to the measured outcomes, we noticed that overall BPD severity and some individual outcomes were not always measured. Therefore, it would be very helpful if future studies incorporated assessments with the Zanarini Rating Scale for BPD (ZAN-BPD), the Borderline Symptom List (BSL), the BPD Severity Index (BPDSI) or the Borderline Evaluation of Severity over Time (BEST) ([@bibr49-0004867418791257]). Also, more attention should be paid to some individual BPD outcomes, for example, results on 'identity disturbance' and 'feelings of emptiness' outcomes have not been meta-analyzed because they were not reported or were not extractable in the included studies. A third point that could lead to a stronger evidence base is the way results are meta-analyzed. In a post hoc analysis, we showed that the evidence base could be stronger when data are aggregated on the highest possible level, that is, when combined studies compared specialized psychotherapies with TAU and CTBE. Fourth and finally, it might be worthwhile to undertake a network meta-analysis, thereby enlarging the power of the study data and enabling a comparison of interventions that have not yet been compared directly in RCTs.
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